相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-term clinical outcomes of imiquimod 5% cream vs. diclofenac 3% gel for actinic keratosis on the face or scalp: a pooled analysis of two randomized controlled trials
H. Gollnick et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
A trial-based cost-effectiveness analysis of topical 5-fluorouracil vs. imiquimod vs. ingenol mebutate vs. methyl aminolaevulinate conventional photodynamic therapy for the treatment of actinic keratosis in the head and neck area performed in the Netherlands
M. H. E. Jansen et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma – short version, part 1: diagnosis, interventions for actinic keratoses, care structures and quality‐of‐care indicators
Markus V. Heppt et al.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2020)
Cash is king: the balance of costs and effectiveness of treatments for actinic keratosis
T. Steeb et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Cutaneous squamous cell carcinomas are associated with basal proliferating actinic keratoses
L. Schmitz et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
Randomized Trial of Four Treatment Approaches for Actinic Keratosis
Maud H. E. Jansen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Somatic mutations in kinetochore gene KNSTRN are associated with basal proliferating actinic keratoses and cutaneous squamous cell carcinoma
L. Schmitz et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2019)
The Evidence Project risk of bias tool: assessing study rigor for both randomized and non-randomized intervention studies
Caitlin E. Kennedy et al.
SYSTEMATIC REVIEWS (2019)
Phase IV head-to-head randomized controlled trial comparing ingenol mebutate 0 center dot 015% gel with diclofenac sodium 3% gel for the treatment of actinic keratosis on the face or scalp
E. Stockfleth et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
A multicentre, open, investigator-initiated phase IV clinical trial to evaluate the efficacy and safety of ingenol mebutate gel, 0•015% on the face and scalp, and 0•05% on the trunk and extremities, in Korean patients with actinic keratosis (PERFECT)
Y. C. Kim et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
A randomized intraindividual comparative study of methyl-5-aminolaevulinate vs. 5-aminolaevulinic acid nanoemulsion (BF-200 ALA) in photodynamic therapy for actinic keratosis of the face and scalp
C. Serra-Guillen et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
Photodynamic therapy with a 5-ALA patch does not increase the risk of conversion of actinic keratoses into squamous cell carcinoma Results of a multicentre non-interventional study
Uwe Reinhold et al.
EXPERIMENTAL DERMATOLOGY (2018)
Low-dose 5-fluorouracil in combination with salicylic acid for the treatment of actinic keratoses on the hands and/or forearms - results of a non-interventional study
U. Reinhold et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)
British Association of Dermatologists' guidelines for the care of patients with actinic keratosis 2017
D. de Berker et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
A randomized, double-blind, phase III, multicentre study to evaluate the safety and efficacy of BF-200 ALA (Ameluz®) vs. placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-RhodoLED® lamp
U. Reinhold et al.
BRITISH JOURNAL OF DERMATOLOGY (2016)
Efficacy of low-dose 5-fluorouracil/salicylic acid in actinic keratoses in relation to treatment duration
Rolf-Markus Szeimies et al.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2015)
Network meta-analysis of the outcome 'participant complete clearance' in nonimmunosuppressed participants of eight interventions for actinic keratosis: a follow-up on a Cochrane review
A. K. Gupta et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
A Pathway to Improved Prospective Observational Post-Authorization Safety Studies
Victor A. Kiri
DRUG SAFETY (2013)
Ingenol Mebutate Gel for Actinic Keratosis
Mark Lebwohl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Comparison of topical 3% diclofenac sodium gel and 5% imiquimod cream for the treatment of actinic keratoses
S. Akarsu et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2011)
Topical 3.0% diclofenac in 2.5% hyaluronic acid gel induces regression of cancerous transformation in actinic keratoses
T. Dirschka et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2010)
Comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% imiquimod cream in the treatment of actinic keratosis
Osman Kose et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2008)
Importance and challenges of studying marketed drugs: What is a phase IV study? Common clinical research designs, registries, and self-reporting systems
Stephen P. Glasser et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Photodynamic therapy using aminotaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up
E. H. Tschen et al.
BRITISH JOURNAL OF DERMATOLOGY (2006)
A refined method for the meta-analysis of controlled clinical trials with binary outcome
J Hartung et al.
STATISTICS IN MEDICINE (2001)
Epidemiology of actinic keratoses and squamous cell carcinoma
SJ Salasche
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2000)
Clinical presentation of actinic keratoses and squamous cell carcinoma
RL Moy
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2000)
分享论文
